Medtronic is bringing on a new chief medical officer for its digital and robotics teams, who it described as one of the top ...

Medtronic (NYSE: MDT) says Dr. James Porter joined the company as CMO of Robotic Surgical Technologies and Digital ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

Medtronic reported adjusted earnings per share of $1.23 for ... The company generates revenues from four major segments, namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience ...

From new leadership and expansions, here are five key updates from spine and orthopedic devicemakers since Sept. 11.

Medtronic appoints Dr. James Porter as CMO for robotic and digital technologies, tasked with driving innovation and clinical evidence plans.

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical ...

But for its surgical robotics business, Medtronic needed a more prominent space so it can recruit talent and form partnerships with nearby research universities, said Mike Marinaro, president of ...

Medtronic plc (NYSE:MDT) is one of the largest medical device ... neurovascular products, advanced energy, and surgical tools ...

Medtronic's business is diversified. The company boasts dozens of devices across four main segments: Medical surgical, neuroscience, cardiovascular, and diabetes. Though Medtronic records ...

The company operates in four business segments: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. Medtronic sells products in many end markets in these segments. It is usually the ...